Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in J Clin Oncol

Retrieve available abstracts of 29 articles:
HTML format

Single Articles

    September 2021
    A Step Forward in Realizing the Promise of Genomic Medicine for Childhood Rhabdomyosarcoma.
    J Clin Oncol. 2021;39:2851-2854.

  2. SHERN JF, Selfe J, Izquierdo E, Patidar R, et al
    Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium.
    J Clin Oncol. 2021;39:2859-2871.
    PubMed     Abstract available

    April 2021
  3. BERSANELLI M, Travaglino E, Meggendorfer M, Matteuzzi T, et al
    Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes.
    J Clin Oncol. 2021;39:1223-1233.
    PubMed     Abstract available

  4. MURPHY AB, Abern MR, Liu L, Wang H, et al
    Impact of a Genomic Test on Treatment Decision in a Predominantly African American Population With Favorable-Risk Prostate Cancer: A Randomized Trial.
    J Clin Oncol. 2021 Apr 9:JCO2002997. doi: 10.1200/JCO.20.02997.
    PubMed     Abstract available

    February 2021
  5. CREW KD, Hershman DL
    Better Together: Clinical and Genomic Data to Inform Shared Decision Making.
    J Clin Oncol. 2021;39:545-547.

    January 2021
  6. KUMAR R, Smith KS, Deng M, Terhune C, et al
    Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma.
    J Clin Oncol. 2021 Jan 27:JCO2001359. doi: 10.1200/JCO.20.01359.
    PubMed     Abstract available

  7. KALINSKY K, Thomas A, Cescon DW
    On the Road to Precision: Understanding the Biology Driving Genomic Assays.
    J Clin Oncol. 2021;39:100-102.

  8. GAJJAR A, Robinson GW, Smith KS, Lin T, et al
    Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).
    J Clin Oncol. 2021 Jan 6:JCO2001372. doi: 10.1200/JCO.20.01372.
    PubMed     Abstract available

    November 2020
  9. AMBROS IM, Tonini GP, Potschger U, Gross N, et al
    Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group.
    J Clin Oncol. 2020;38:3685-3697.
    PubMed     Abstract available

    October 2020
  10. CROMBIE JL, Armand P
    Diffuse Large B-Cell Lymphoma's New Genomics: The Bridge and the Chasm.
    J Clin Oncol. 2020;38:3565-3574.

    July 2020
  11. LONIAL S, Dhodapkar MV, Rajkumar SV
    Smoldering Myeloma and the Art of War.
    J Clin Oncol. 2020;38:2363-2365.

  12. BUSTOROS M, Sklavenitis-Pistofidis R, Park J, Redd R, et al
    Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression.
    J Clin Oncol. 2020;38:2380-2389.
    PubMed     Abstract available

    May 2020
  13. LIN DW, Zheng Y, McKenney JK, Brown MD, et al
    17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) Cohort.
    J Clin Oncol. 2020;38:1549-1557.
    PubMed     Abstract available

  14. KURIAN AW, Katz SJ
    Emerging Opportunity of Cascade Genetic Testing for Population-Wide Cancer Prevention and Control.
    J Clin Oncol. 2020;38:1371-1374.

  15. FREY MK, Kahn RM, Chapman-Davis E, Tubito F, et al
    Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling.
    J Clin Oncol. 2020;38:1389-1397.
    PubMed     Abstract available

    April 2020
  16. ROBINSON GW, Gajjar A
    Genomics Paves the Way for Better Infant Medulloblastoma Therapy.
    J Clin Oncol. 2020 Apr 30:JCO2000593. doi: 10.1200/JCO.20.00593.

  17. TREON SP, Xu L, Guerrera ML, Jimenez C, et al
    Genomic Landscape of Waldenstrom Macroglobulinemia and Its Impact on Treatment Strategies.
    J Clin Oncol. 2020;38:1198-1208.
    PubMed     Abstract available

    March 2020
  18. FREEMAN S, Craddock C
    Less Is Not Necessarily More: Toward a Rational Selection of the Conditioning Regimen in Acute Myeloid Leukemia.
    J Clin Oncol. 2020 Mar 2:JCO1903161. doi: 10.1200/JCO.19.03161.

    February 2020
  19. HASSETT MJ, Somerfield MR, Baker ER, Cardoso F, et al
    Management of Male Breast Cancer: ASCO Guideline.
    J Clin Oncol. 2020 Feb 14:JCO1903120. doi: 10.1200/JCO.19.03120.
    PubMed     Abstract available

    January 2020
  20. KONSTANTINOPOULOS PA, Norquist B, Lacchetti C, Armstrong D, et al
    Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
    J Clin Oncol. 2020 Jan 27:JCO1902960. doi: 10.1200/JCO.19.02960.
    PubMed     Abstract available

  21. PATEL JN, McLeod HL
    Clarity Also Needed for Direct-to-Consumer Pharmacogenetic Tests.
    J Clin Oncol. 2020;38:283-284.

    December 2019
  22. HAYES DF, Rae JM
    Pharmacogenomics and Endocrine Therapy in Breast Cancer.
    J Clin Oncol. 2019 Dec 27:JCO1903119. doi: 10.1200/JCO.19.03119.

  23. EGGENER SE, Rumble RB, Armstrong AJ, Morgan TM, et al
    Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline.
    J Clin Oncol. 2019 Dec 12:JCO1902768. doi: 10.1200/JCO.19.02768.
    PubMed     Abstract available

    June 2019
  24. GOETZ MP, Suman VJ, Nakamura Y, Kiyotani K, et al
    Tamoxifen Metabolism and Breast Cancer Recurrence: A Question Unanswered by CYPTAM.
    J Clin Oncol. 2019 Jun 18:JCO1900504. doi: 10.1200/JCO.19.00504.

    April 2019
  25. GIRI VN, Hyatt C, Gomella LG
    Germline Testing for Men With Prostate Cancer: Navigating an Expanding New World of Genetic Evaluation for Precision Therapy and Precision Management.
    J Clin Oncol. 2019 Apr 12:JCO1802181. doi: 10.1200/JCO.18.02181.

    March 2019
  26. SANCHEZ-SPITMAN A, Dezentje V, Swen J, Moes DJAR, et al
    Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study.
    J Clin Oncol. 2019;37:636-646.
    PubMed     Abstract available

    February 2019
  27. VOLTA AD, Cosentini D, Antonelli A, Pedersini R, et al
    Transformation of Prostate Adenocarcinoma Into Small-Cell Neuroendocrine Cancer Under Androgen Deprivation Therapy: Much Is Achieved But More Information Is Needed.
    J Clin Oncol. 2019;37:350-351.

  28. AGGARWAL R, Huang J, Alumkal J, Feng FY, et al
    Reply to A. Dalla Volta et al.
    J Clin Oncol. 2019;37:351-352.

    January 2019
  29. STOFFEL EM, McKernin SE, Brand R, Canto M, et al
    Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion.
    J Clin Oncol. 2019;37:153-164.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Genetics is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.